Thrombin-dependent regulation of matrix metalloproteinase (MMP)-9 levels in human fetal membranes

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 18, Issue 1, 2005, Pages 17-22

  Stephenson, Courtney D ^a   Lockwood, Charles J ^b   Ma, Yuehong ^b   Guller, Seth ^b  

^a CAROLINAS MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fetal membranes; Matrix metalloproteinases; Premature membrane rupture; Thrombin

Indexed keywords

DEXAMETHASONE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBIN RECEPTOR ACTIVATING PEPTIDE 14; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

AMNION; ARTICLE; BLEEDING; CHORION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; FETUS; FETUS MEMBRANE; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LABOR; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; TISSUE CULTURE;

ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; EXTRAEMBRYONIC MEMBRANES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; ORGAN CULTURE TECHNIQUES; PEPTIDE FRAGMENTS; PREGNANCY; THROMBIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 24044528534     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050500123632     Document Type: Article

References (30)

1. Harger JH, Hsing AW, Tuomala RE, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130-137.
2. Tucker J, McGuire W. Epidemiology of preterm birth. BMJ 2004;329:675-678.
3. Menon R, Fortunato SJ. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Invest 2004;11:427-437.
4. Lei H, Furth EE, Kalluri R, et al. A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Invest 1996;98:1971-1978.
5. Parry S, Strauss JF, 3rd. Premature rupture of the fetal membranes. N Engl J Med 1998;338:663-670.
6. Fortunato SJ, Menon R, Bryant C, et al. Programmed cell death (apoptosis) as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes. Am J Obstet Gynecol 2000;182: 1468-1476.
7. Athanyde N, Romero R, Gomez R, et al. Matrix metalloproteinase-9 in preterm and term human parturition. J Matern Fetal Med 1999;8:213-219.
8. Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, et al. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinase-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996;174:1371-1376
9. Athayde N, Edwin SS, Romero R, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol 1998;179:1248-1253.
10. Williams MA, Mittendorf R, Lieberman E, et al. Adverse infant outcomes associated with first-trimester vaginal bleeding. Obstet Gynecol 1991;78:14-18.
11. Salafia CM, López-Zeno JA, Sherer DM, et al. Histological evidence of old uterine bleeding is more frequent in prematurity. Am J Obstet Gynecol 1995;173:1065-1070.
12. Lockwood CJ, Nemerson Y, Guller S, et al. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Clin Endocrinol Metab 1993;76:231-236.
13. Lockwood CJ, Krikun G, Schatz F. Decidual cell-expressed tissue factor maintains hemostasis in human endometrium. Ann NY Acad Sci 2001;943:77-88.
14. Sere KM, Hackeng TM. Basic mechanisms of hemostasis. Sem Vasc Med 2003;3:3-1.
15. Anrather D, Millan MT, Palmetshofer A, et al. Thrombin activates nuclear factor-κB and potentiates endothelial cell activation by TNF. J Immunol 1997;159:5620-5628.
16. Rosen T, Kuczynski E, O'Neill LM, et al. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med 2001;10:297-300.
17. Yoon DY, Ma Y, Krikun G, et al. Glucocorticoid effects in the human placenta: evidence that dexamethasone-mediated inhibition of fibronectin expression in cytotrophoblasts involves a protein intermediate. J Clin Endocrinol Metab 1998;83:632-637.
18. Fortunato SJ, Menon R, Swan KF, et al. Organ culture of amniochorionic membrane in vitro. Am J Reprod Immunol 1994;32:184-187.
19. Menon R, Swan KF, Lyden TW, et al. Expression of inflammatory cytokines (interleukin-1 beta and interleukin-6) in amniochorionic membranes. Am J Obstet Gynecol 1995;172:493-500.
20. Vu TK, Hung DT, Wheaton VI, et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057-1068.
21. Maruyama Y, Maruyama I, Soejima Y. Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun 1994;199:1262-1269.
22. Fortunato SJ, Lombardi SJ, Menon R. Immunoreactivity of human fetal membranes peptidoglycan polysaccharide (PGPS): cytokine response. J Perinat Med 1998;26:442-447.
23. Auphan N, DiDonato JA, Rosette C, et al. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 1995;270:286-290.
24. Rosen T, Schatz F, Kuczynski E, et al. Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. J Matern Fetal Neonatal Med 2002;11:11-17.
25. Mackenzie AP, Schatz F, Krikun G, et al. Mechanisms of abruption-induced premature rupture of fetal membranes: Thrombin enhanced decidual matrix metalloproteinase-3 (stromelysin-1) expression. Am J Obstet Gynecol 2004;191: 1996-2001.
26. Fortunato SJ, Menon R, Lombardi SJ. Role of tumor necrosis factor-α in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol 2002;187:1159-1162.
27. Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002;346:3719-3727.
28. Lockwood CJ. Predicting premature delivery-No easy task. N Eng J Med 2002;346:282-284.
29. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci (USA) 1994;91:752-756.
30. Sato H, Seiki M. Regulatory mechanism of 92 kDA type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993;8:395-405.